semaglutide fda approved for weight loss The FDA's Decision to Ban

Worth a watch and Id love to hear where others land on this

Regul Pept (1981) 2:13950

While using Semaglutide GLP-1 , some people may experience mild side effects, such as nausea or stomach discomfort, particularly when starting the treatment

Monitoring of thyroid levels should be considered Warfarin and other coumarin anticoagulants: more frequent INR monitoring is recommended when starting Wegovy, as decreased INR has been reported with acenocoumarol Insulin and sulfonylureas: increased risk of low blood sugar

[23] For weight management patients, decreased potency typically results in reduced appetite suppression and slower gastric emptying effects, potentially leading to weight regain or plateau

If using your thigh, inject on the outer upper thigh, not the inner thigh